Anal self-exam is a valuable screening tool for anal cancer in sexual and gender minority persons

Affiliations

¹ University of Miami Miller School of Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, Miami, FL, USA.
² University of Miami Miller School of Medicine, USA.

Lydia A Fein et al. Lancet Reg Health Am. 2024.

. 2024 Apr 9:33:100742.

doi: 10.1016/j.lana.2024.100742. eCollection 2024 May.

¹ University of Miami Miller School of Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, Miami, FL, USA.
² University of Miami Miller School of Medicine, USA.

No abstract available

Conflict of interest statement

No conflicts of interest.

1. Jackson S.S., Han X., Mao Z., et al. Cancer stage, treatment, and survival among transgender patients in the United States. J Natl Cancer Inst. 2021;113(9):1221–1227. - PMC - PubMed
1. Cancer disparities Report.org. American Association for Cancer Research; Philadelphia: 2022. www.cancerdisparitiesprogressreport.org Available from:
1. Nyitray A.G., McAuliffe T.L., Liebert C., et al. The accuracy of anal self- and companion exams among sexual minority men and transgender women: a prospective analysis. Lancet Reg Health Am. 2024;31 doi: 10.1016/j.lana.2024.100704. - DOI - PMC - PubMed
1. Deshmukh A.A., Suk R., Shiels M.S., et al. Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001–2015. J Natl Cancer Inst. 2020;112(8):829–838. - PMC - PubMed
1. Fein L.A., Cunha I.R., Wong A., Schlumbrecht M.P., Duthely L.M., Potter J.E. Low perceived anal cancer risk and screening utilization among high-risk transgender men and women living in an HIV/STI epicenter. AIDS Behav. 2021;25(7):2210–2218. - PubMed